From Wall Street to wombs: How one woman built a surrogacy empire
From Wall Street to wombs: How one woman built a surrogacy empire
From Wall Street to wombs: How one woman built a surrogacy empire
Angela Richardson-Mook started her career in finance before becoming a surrogate at 26. Over 13 years, she carried six babies for three different families. Now, she runs a successful surrogacy agency while balancing work and family life. Richardson-Mook first worked in corporate roles, including a position as Vice President of Program Operations at Bank of America. There, she managed a team of 100 people. Later, she moved into consulting, leading technology projects as Chief Project Management Officer at a financial firm.
At 26, she decided to become a surrogate for the first time. By then, she already had three children of her own and was studying nursing. Over the next 13 years, she carried six babies for three families. In 2019, she founded Alcea Surrogacy, an agency focused on ethical surrogacy practices. The business has since grown to 23 employees and expanded into four main areas. Today, it generates $5 million in annual revenue. Richardson-Mook now earns more from her agency than she did in her highest-paying corporate job. Despite her busy schedule, she still makes time for her family, including her youngest child, a toddler. Often, she works late into the night to keep everything running smoothly.
Alcea Surrogacy continues to grow, with 23 staff and $5 million in yearly revenue. Richardson-Mook’s shift from finance to surrogacy has proven both personally and financially rewarding. She remains committed to balancing her business with her role as a mother.
German nursing care reform faces delay as DAK-Gesundheit demands major revisions
A last-minute plea to halt the reform exposes deep flaws in Germany's care system. Will the government rewrite the rules—or risk financial chaos for families and towns?
Region's healthcare transformation brings new hospitals and cutting-edge upgrades
From rural clinics to urban polyclinics, this region's healthcare overhaul is setting new standards. Discover how 149 new facilities and global-trained doctors are reshaping patient care.
FDA's peptide safety review sparks conflict-of-interest concerns this July
From muscle growth to anti-aging, peptides promise miracles—but can the FDA's review be trusted with insiders profiting from the same drugs? A deep dive into the controversy.
Debt repayments now outpace healthcare spending in poorer nations
Kenya spends 29% of revenue on debt—three times its healthcare budget. The IMF's austerity push deepens inequality and strains public services.